Abstract
The year 2019 has offered up many advances in immunotherapy. These advances shed light on such important aspects as biomarkers, better targeted therapies, chemotherapy outcomes, and resistance. Summarized herein are several high-profile conference presentations that highlight key advances in the field.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials as Topic / statistics & numerical data*
-
Humans
-
Immunotherapy / methods*
-
Immunotherapy / trends
-
Molecular Targeted Therapy / methods*
-
Molecular Targeted Therapy / trends
-
Neoplasms / drug therapy*
-
Neoplasms / immunology
-
Prognosis